Actemra®
Actemra® (tocilizumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, thereby helping to protect healthy cells from damage. Specifically, it is an interleukin-6 (IL-6) receptor antagonist used to treat various types of arthritis by reducing the effects of a substance in the body that can cause inflammation.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Genentech |
CLASS: Biologics (Interleukin-6 inhibitor) |
PRESCRIBED BY: Rheumatologists |
HOW ADMINISTERED: Most often given by IV infusion but in some cases also by subcutaneous injection. |
FREQUENCY: Administered every four weeks for RA, once a week for GCA, and every two, three, or four weeks for JIA. |
Length of infusion: About 60 minutes |
FOR MORE INFORMATION: |
